Request Deal Involvement
Xoma Royalty-backed XRA 5 to acquire Mural Oncology for $36.2m.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
legal advisors
Arthur Cox
legal advisors
WilmerHale
financial advisors
Lucid Capital Markets
pr advisors
KV Management
legal advisors
Mason Hayes & Curran
financial advisors
Davy Corporate Finance
legal advisors
Gibson Dunn & Crutcher
or
Principals
bidder
XRA 5 CORP
target
MURAL ONCOLOGY
bidder
XOMA ROYALTY
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite